Stock News

Thomaspartners Has Boosted Its Johnson & Johnson (JNJ) Stake; 3 Analysts Covering TECHNIP SPON ADR EA REP 1/4 ORD (TKPPY)

Johnson & Johnson (NYSE:JNJ) Logo

Among 7 analysts covering Technip (OTCMKTS:TKPPY), 3 have Buy rating, 2 Sell and 2 Hold. Therefore 43% are positive. Technip had 7 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Mkt Perform” rating on Wednesday, January 6 by Bernstein. The rating was upgraded by Macquarie Research on Wednesday, November 4 to “Outperform”. The rating was initiated by Jefferies on Monday, October 5 with “Buy”. On Wednesday, July 22 the stock rating was upgraded by Goldman Sachs to “Neutral”. The firm has “Reduce” rating by Nomura given on Tuesday, September 8. The stock of TECHNIP SPON ADR EA REP 1/4 ORD (OTCMKTS:TKPPY) earned “Sell” rating by Citigroup on Monday, October 12. Credit Suisse initiated the stock with “Outperform” rating in Monday, September 19 report. See TECHNIP SPON ADR EA REP 1/4 ORD (OTCMKTS:TKPPY) latest ratings:

Thomaspartners Inc increased Johnson & Johnson (JNJ) stake by 2.24% reported in 2018Q1 SEC filing. Thomaspartners Inc acquired 68,116 shares as Johnson & Johnson (JNJ)’s stock declined 8.03%. The Thomaspartners Inc holds 3.11 million shares with $398.08 million value, up from 3.04 million last quarter. Johnson & Johnson now has $328.86B valuation. The stock increased 0.16% or $0.2 during the last trading session, reaching $122.61. About 13.17M shares traded or 99.03% up from the average. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 18, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: ; 05/04/2018 – J&J, IMERYS FOUND LIABLE FOR CLAIMS TALC TAINTED BY ASBESTOS; 16/04/2018 – J&J SAYS ESKETAMINE PRIMARY EFFICACY ENDPOINT WAS ACHIEVED; 17/04/2018 – JNJ SAYS ACTELION IS DELIVERING AS EXPECTED; 18/04/2018 – Kentucky Gov. Matt Bevin slams state AG’s lawsuit against J&J: ‘These are political moves’; 18/04/2018 – Kentucky A.G. Beshear Sues Johnson & Johnson Over Deceptive Marketing Scheme That Fueled Opioid Epidemic; 17/04/2018 – J&J SEES FY ADJ EPS $8.00 TO $8.20; 26/03/2018 – Hartford Dividend and Growth Adds AT&T, Cuts J&J; 17/04/2018 – J&J JNJ.N REAFFIRMS FY 2018 ADJUSTED SHR VIEW $8.00 TO $8.20; 11/04/2018 – JOHNSON & JOHNSON JNJ.N , IMERYS SA IMTP.PA SUBSIDIARY ORDERED TO PAY $80 MLN IN PUNITIVE DAMAGES IN NEW JERSEY CASE BLAMING TALC FOR MESOTHELIOMA -COURTROOM VIDEO; 17/04/2018 – J&J – PLANS TO IMPLEMENT ACTIONS ACROSS ITS GLOBAL SUPPLY CHAIN

The stock decreased 1.03% or $0.19 during the last trading session, reaching $17.85. It is down 0.00% since June 18, 2017 and is . It has underperformed by 12.57% the S&P500.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. RBC Capital Markets maintained it with “Buy” rating and $138.0 target in Sunday, August 27 report. The stock has “Buy” rating by Jefferies on Monday, February 26. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Monday, July 10 by BMO Capital Markets. The firm earned “Hold” rating on Friday, July 14 by Jefferies. The company was upgraded on Wednesday, July 20 by Argus Research. The firm earned “Buy” rating on Wednesday, October 18 by Jefferies. Goldman Sachs maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, April 20. Goldman Sachs has “Neutral” rating and $114 target. RBC Capital Markets maintained it with “Outperform” rating and $128 target in Wednesday, January 25 report. The rating was maintained by Wells Fargo with “Buy” on Wednesday, April 18. Leerink Swann maintained the shares of JNJ in report on Wednesday, April 18 with “Buy” rating.

Since February 15, 2018, it had 0 insider buys, and 1 sale for $20.17 million activity. Shares for $20.17 million were sold by Stoffels Paulus on Thursday, February 15.

Investors sentiment increased to 0.93 in 2018 Q1. Its up 0.06, from 0.87 in 2017Q4. It improved, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Dixon Hubard Feinour And Brown Inc Va, a Virginia-based fund reported 81,330 shares. Nexus Invest Management holds 10,726 shares. Miller Management LP has invested 0.75% in Johnson & Johnson (NYSE:JNJ). Silvercrest Asset Management Limited Liability has 701,304 shares. Vaughan Nelson Inv Mgmt Limited Partnership invested 0.3% in Johnson & Johnson (NYSE:JNJ). Coldstream Cap Mgmt has 0.59% invested in Johnson & Johnson (NYSE:JNJ). Blb&B Ltd Liability Corp has 2.27% invested in Johnson & Johnson (NYSE:JNJ). Baker Avenue Asset Mngmt Lp reported 0.54% in Johnson & Johnson (NYSE:JNJ). Farr Miller & Washington Ltd Company Dc has 309,544 shares for 3.69% of their portfolio. Bennicas & Associate Inc has 9,000 shares. Hengehold Capital Management Limited Liability Company owns 17,309 shares or 0.58% of their US portfolio. Groesbeck Mngmt Corporation Nj holds 0.19% or 2,000 shares. Moreover, Van Hulzen Asset Mngmt Limited Liability has 1.76% invested in Johnson & Johnson (NYSE:JNJ) for 44,944 shares. 19,773 were accumulated by Tiemann Investment Lc. Forte Capital Ltd Llc Adv holds 1.04% or 19,340 shares in its portfolio.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *